ARAY Stock Forecast: Accuray, Inc. Price Predictions for 2026-2027
The median 12-month analyst price target for Accuray, Inc. is $0.35. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 46 of 100 as at 21 Nov 2026 — in the lower half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Accuray, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (74): The share count has been shrinking and the company is not leaning on new borrowing.
Momentum (19): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
ARAY stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on ARAY, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 12 May 2026 | Jefferies | Downgrade | Hold | $3.50 → $0.35 |
| 7 May 2026 | BTIG | Downgrade | Neutral | — |
| 5 Feb 2026 | BTIG | Maintains | Buy | — |
| 6 Nov 2025 | BTIG | Maintains | Buy | — |
| 14 Aug 2025 | BTIG | Maintains | Buy | — |
| 13 Feb 2024 | Roth MKM | Initiates | Buy | — |
| 4 Oct 2023 | B. Riley Securities | Reiterates | Buy | — |
| 31 Aug 2022 | B. Riley Securities | Initiates | Buy | — |
| 24 June 2022 | BTIG | Maintains | Buy | — |
| 23 June 2022 | B. Riley Securities | Initiates | Buy | — |
| 22 Dec 2021 | Loop Capital | Initiates | Buy | — |
| 21 Jan 2020 | BTIG | Upgrade | Buy | — |
| 21 Jan 2020 | BTIG Research | Upgrade | Buy | — |
| 1 Nov 2018 | Citigroup | Upgrade | Neutral | — |
| 17 Aug 2018 | Citigroup | Maintains | Sell | — |
| 19 Dec 2017 | JP Morgan | Downgrade | Underweight | — |
| 13 Dec 2017 | JP Morgan | Downgrade | Underweight | — |
| 30 Nov 2017 | Lake Street | Initiates | Buy | — |
| 23 Aug 2017 | Jefferies | Maintains | Buy | — |
| 6 Feb 2017 | Aegis Capital | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for ARAY.
This page is one stock. Monday covers all of them.
ARAY appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
ARAY vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Accuray, Inc. returned −94.5% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
ARAY analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 0.0×
- Price / book
- 0.1×
- EV / EBITDA
- 23.8×
Cheaper than 99% of US stocks
Cheaper than 95% of US stocks
Cheaper than 16% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 34.8%
- Operating margin
- −0.6%
- Net margin
- —
Higher than 41% of US stocks
Higher than 34% of US stocks
- Return on equity
- −30.2%
- Return on assets
- −0.4%
- Dividend yield
- —
Higher than 28% of US stocks
Higher than 42% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Accuray, Inc. has a market value of $6.4M and an enterprise value of $100.1M.
Revenue in the twelve months to 30 June 2026: $401.9M. The latest quarter shrank 20.9% year on year.
Net income over the same four quarters: −$49.2M, a −12.2% net margin.
Diluted earnings per share, trailing twelve months: −$0.40.
Free cash flow in the twelve months to 30 June 2026: −$19.3M, after $6.4M of capital spending.
Accuray, Inc. employs 809 people — $497K of revenue per employee.
Data provided by Twelve Data
ARAY and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at ARAY’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Accuray, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about ARAY
What is the ARAY stock price forecast for 2026-2027?
The median 12-month analyst price target for Accuray, Inc. is $0.35. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is ARAY stock a buy right now?
Of the 1 analyst covering Accuray, Inc., 0 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Accuray, Inc. 46 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank ARAY?
As at 21 Nov 2026, Accuray, Inc. ranks 46 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Issuance (74 of 100).
Will ARAY stock go up?
No one can know that. What the data says: the median 12-month target from 1 analyst is $0.35, and Ticker Nerd's factor model ranks Accuray, Inc. 46 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the ARAY stock forecast for 2030?
No analyst covering Accuray, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ARAY are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $0.35 to $0.35 over the next 12 months.
How has ARAY stock performed over the past year?
Accuray, Inc. returned -94.5% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Accuray, Inc. do?
Accuray Incorporated is a medical device company that develops, manufactures, sells, and supports advanced radiation therapy systems for cancer treatment. The company’s portfolio centers on the CyberKnife and Radixact platforms, which are designed to deliver precise, image-guided treatments for tumors and other complex clinical cases.
About Accuray, Inc.
Accuray Incorporated is a medical device company that develops, manufactures, sells, and supports advanced radiation therapy systems for cancer treatment. The company’s portfolio centers on the CyberKnife and Radixact platforms, which are designed to deliver precise, image-guided treatments for tumors and other complex clinical cases. Accuray also provides treatment planning software, motion management tools, and service offerings that support hospitals, cancer centers, and academic medical institutions. Its products are used across radiation oncology, stereotactic radiosurgery, and other specialized treatment workflows, giving the company a role in the broader market for precision oncology technologies. Accuray Incorporated focuses on combining hardware, software, and clinical support to help healthcare providers deliver targeted radiation therapy with greater accuracy and flexibility.
CEO Mr. Stephen R. LaNeve MBA · 809 employees · United States · https://www.accuray.com